Detalhe da pesquisa
1.
Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial.
J Urol
; 204(3): 531-537, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32250730
2.
3.
Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors.
Invest New Drugs
; 33(5): 1040-7, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26091915
4.
A phase I study of temsirolimus and bryostatin-1 in patients with metastatic renal cell carcinoma and soft tissue sarcoma.
Oncologist
; 19(4): 354-5, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24674872
5.
Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma.
Clin J Oncol Nurs
; 12(4): 639-46, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18676330